The Basser Center Monthly Seminar Series is held at noon on the first of the month in the Smilow Translational Research Center. The Basser Center also sponsors a scientific symposium.
For more information on seminars and symposia, email Basser Administrative Director, Beth Stearman.
June 5, 2015, 12:00 - 1:00 pm | SCTR 10-146AB
Kara Maxwell, MD, PhD - “The Genomic Landscape of BRCA1/2-associated Breast and Ovarian Tumors”
July 10, 2015, 12:00 - 1:00 pm | SCTR 10-146AB
Fiona Simpkins, MD
January 9, 2015
Robert H. Vonderheide, MD, DPhil - "Prospects of Immune Prevention of BRCA1/2 Cancer"
December 5, 2014
Roger A. Greenberg, MD, PhD - "Using Mice to Understand BRCA Function"
November 7, 2014
Benjamin Garcia, PhD - "Quantitative Proteomics for Analyzing Cellular Function"
October 3, 2014
Andy Minn, MD, PhD - "Targeting and Function of Pathways Regulating Breast Cancer Treatment Resistance"
September 5, 2014
Erica Carpenter, MBA, PhD - "Circulating Tumor Material and Noninvasive Personalized Diagnostics: Recent Developments and Future Directions"
July 11, 2014
Kate Nathanson, MD - "A review of massively parallel sequencing and how to use the data generated"
June 6, 2014
Lin Zhang, MD - "Novel approaches to treating and understanding BRCA2-related ovarian cancer using the zebrafish"
Michael A. Pack, MD - "A clinically guided genomic approach identifies the BRCAness of breast and ovarian cancer"
May 2, 2014
Eric Brown, PhD - "ATR-CHK1 Pathway inhibition as a treatment for BRCA1/2-deficient cancers"
David Weiner, PhD - "Developing a DNA immune therapy target hTERT: prospect of immunoprevention of BRCA1/2 related cancers "
January 3, 2014 - Event canceled due to weather.
David Weiner, PhD: "Developing a DNA immune therapy target hTERT: prospect of immunoprevention of BRCA1/2 related cancers"
December 6, 2013
Kate Nathanson, MD: "Somatic mutations in BRCA1/2 associated tumors"
Tim Rebbeck, PhD: "Mutation-specific risks in BRCA1/2 mutations carriers"
November 1, 2013
Andy Minn, MD, PhD: "Tumor and stroma pathways regulating breast cancer tratment resistance"
Andrea Facciabene, PhD: "Targeting the vasculature, tumor endothelial marker1 HLA-A2 epitopes mapping"
September 6, 2013
Katie Schmitz, PhD, MPH : "Dose response effects of exercise training on endogenous hormones in high risk women: The WISER Sister Trial"
Roger Greenberg, MD, PhD: "Chromatin Determinants of BRCA Function"
Shridar Ganesan, MD, PhD (UMDNJ) - "BRCA1, 53BP1 and PARP: DNA Repair Choice and Chemosensitivity".
May 3, 2013
Ramin Shiekhattar, PhD (Wistar Institute): "Genome-wide Analysis of BRCA Genes Reveals New Functions"
February 1, 2013
Angela Bradbury, MD: "REACH: Research to Evaluate Adolescents and Communication of Hereditary Risk"
Andy Minn, MD, MPH: "Regulation and Function of Interferon-Stimulated Genes that Promote DNA Damage Resistance in Triple Negative and BRCA1 mutant Breast Cancer"
January 4, 2013
Andy Rhim, MD: "Using GEDI to Detect Circulating Epithelial Cells"
Chunsheng Li, PhD: "Development of Molecular Imaging of Tumor Vasculature for the Early Detection of Hereditary Ovarian and Breast Cancer"
December 7, 2012
Tim Rebbeck, PhD: "Why Do BRCA1/2 Confer Breast Cancer in Some Women and Ovarian Cancer in Others?"
Kara Maxwell, MD, PhD: "A Case of an Adult with Biallelic BRCA2 Mutations and an Atypical Phenotype"
October 5, 2012
Andrea Faccibene, PhD: "Development of Vaccine Targeting the Tumor Vasculature for the Prevention of BRCA-deficient Tumors"
Susan Domchek, MD: "Cancer Risk Evaluation Program: Current and Future Biobank"